Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Rhythm Pharmaceuticals, Inc.
rhythmtx.comAI Executive Summary
AI-powered analysis of 8-K filing content
Rhythm Pharmaceuticals appointed Kimberly J. Popovits as a non-employee director on April 1, 2026, serving as a Class II director until the 2028 annual meeting. This board expansion reflects the company's efforts to strengthen governance and strategic oversight.
Key Takeaways
Kimberly J. Popovits elected as non-employee director effective April 1, 2026
Ms. Popovits will serve as Class II director with term ending at 2028 annual stockholder meeting
2 more takeaways
Related Filings (2)
2 more filings from Rhythm Pharmaceuticals, Inc. in the last 90 days